Trial Profile

A Post-Market Registry of the BioFreedomTM Biolimus A9TM Coated Coronary Stent System

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 05 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Umirolimus (Primary)
Indications Coronary artery disease
Focus Therapeutic Use
Sponsors Biosensors Europe

Most Recent Events

29 Jun 2020 Status changed from recruiting to active, no longer recruiting.
14 Apr 2020 Planned End Date changed from 27 Feb 2022 to 27 Apr 2022.
14 Apr 2020 Planned primary completion date changed from 30 Jan 2021 to 30 Apr 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com